MedTrace Logo

COVID-19 Infection and Reproductive Health in Infertile Women

NCT05435430 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2022-06-28

No results posted yet for this study

Summary

An increased number of women has been infected by COVID-19 in the last 2 years SARS-CoV-2 infection could have a role in potential disturbances on hormon levels and human fertility Has not completely demonstrated COVID-19 effects on female reproductive function and further research can be undertaken.

The proposed multicenter study will be simple and rapid, and attractive for the scientific community.

Conditions

  • Infertility, Female

Interventions

OTHER

PERSPECTIVE, MULTICENTRIC and observational

we will enroll women with 25-45ys old and previously SARS-COV2 infection. first outcome to be investigate the impact of SARS-COV2 infection on female reproductive health and the main clinical-laboratory parameters (FSH, LH, AMH) relating to women with procreative research, in a path of medically procreation assisted programm and on any quantitative variations, duration and periodicity of the menstrual cycle after Covid infection compared to the pre-infection period.

Sponsors & Collaborators

  • University of Palermo

    lead OTHER

Principal Investigators

  • Giuseppe Gullo, MD.Ph.D · AOOR VILLA SOFIA CERVELLO

Eligibility

Min Age
25 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2023-09-30
Completion
2024-03-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05435430 on ClinicalTrials.gov